Rayzebio, Inc.

  • Market Cap: Small Cap
  • Industry: Biotechnology
  • ISIN: US75525N1072
USD
62.49
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Rayzebio, Inc. stock-summary
stock-summary
Rayzebio, Inc.
Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 25 Schemes (10.08%)

Foreign Institutions

Held by 32 Foreign Institutions (6.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-18 Million
stock-summary
Industry

Biotechnology

stock-summary
Market cap

USD 3,814 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.94

stock-summary
Return on Equity

-11.92%

stock-summary
Price to Book

6.63